Cogent Biosciences (COGT) Total Liabilities: 2017-2020
Historic Total Liabilities for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $16.2 million.
- Cogent Biosciences' Total Liabilities fell 23.79% to $18.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $18.1 million, marking a year-over-year decrease of 23.79%. This contributed to the annual value of $16.2 million for FY2020, which is 8.00% down from last year.
- According to the latest figures from FY2020, Cogent Biosciences' Total Liabilities is $16.2 million, which was down 8.00% from $17.7 million recorded in FY2019.
- In the past 5 years, Cogent Biosciences' Total Liabilities ranged from a high of $25.7 million in FY2018 and a low of $16.2 million during FY2020.
- Over the past 3 years, Cogent Biosciences' median Total Liabilities value was $17.7 million (recorded in 2019), while the average stood at $19.9 million.
- As far as peak fluctuations go, Cogent Biosciences' Total Liabilities climbed by 23.46% in 2018, and later slumped by 31.26% in 2019.
- Yearly analysis of 4 years shows Cogent Biosciences' Total Liabilities stood at $20.8 million in 2017, then increased by 23.46% to $25.7 million in 2018, then slumped by 31.26% to $17.7 million in 2019, then declined by 8.00% to $16.2 million in 2020.